Close

Help us reach $1,000,000! Match My Donation

Press Releases

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link
July 08, 2015

Ludwig Cancer Research and the Cancer Research Institute Evaluate Immunotherapeutic Strategies for Brain Cancer and Other Types of Solid Tumors

Ludwig and CRI have launched clinical trials evaluating an immunotherapy for the treatment of the brain cancer glioblastoma multiforme (GBM), and a combination of immunotherapies for a variety of solid tumors.

November 03, 2014

CRI Launches New Features on Immunotherapy Website for Patients and Caregivers

CRI is proud to announce new features to TheAnswerToCancer.org (TheA2C), a first-of-its-kind website and online community devoted specifically to cancer immunotherapy.

September 16, 2014

Cancer Research Institute to Honor Leaders in Cancer Immunotherapy

Murdo Gordon of Bristol-Myers Squibb and CRI Trustee Jacques C. Nordeman will receive the Oliver R. Grace Award at Cancer Research Institute’s 28th Annual Awards Dinner.

September 03, 2014

Ludwig and CRI Collaborate on Evaluation of VentiRx’s Investigational Immunotherapy

The nonprofits announced an agreement with VentiRx Pharmaceuticals Inc., a clinical stage biopharmaceutical company, to conduct a clinical trial with motolimod (VTX-2337) combined with other immunotherapy agents through other industry partnerships.

June 01, 2014

Cancer Research Institute Launches TheAnswerToCancer.org, a Website for Cancer Patients and Caregivers

CRI announces launch of a first-of-its-kind website devoted to cancer immunotherapy, designed specifically for cancer patients and their caregivers, TheAnswerToCancer.org.

*Immunotherapy results may vary from patient to patient.

Top